Administrative Core
行政核心
基本信息
- 批准号:10554471
- 负责人:
- 金额:$ 19.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-14 至 2028-07-31
- 项目状态:未结题
- 来源:
- 关键词:AccountabilityBiometryCancer CenterCancer PatientClinicalClinical ResearchClinical TrialsCommunicationCommunity OutreachComputational BiologyDataData Management ResourcesDevelopmentEnsureEvaluationFeedbackFosteringFutureHealthIndividualInstitutionLeadershipLocally Advanced Malignant NeoplasmMalignant NeoplasmsManuscriptsMichiganMolecular TargetNational Cancer InstituteOffice of Administrative ManagementPatientsPoliciesPopulationPreparationProcessRadiosensitizationRegulationResearchResearch ActivityResearch PersonnelResource InformaticsResourcesSchoolsScientistStructureTranslational ResearchTranslationsUnited States National Institutes of HealthUniversitiesWorkcancer preventioncancer riskcancer therapyflexibilityhealth disparityinnovationmemberorganizational structureprogramsunderserved minority
项目摘要
Project Abstract-Summary (Administrative Core)
The Administrative Core of the University of Michigan Molecularly Targeted Radiosensitization
of Locally Advanced Cancers SPORE (Radiosensitization SPORE) supports all projects, cores,
and developmental programs of the SPORE. The SPORE has well-defined and interactive
organizational structure that includes clearly defined leadership and advisory capabilities
organizational structure serves to meet the specific aims of the SPORE, especially to facilitate
high-impact and innovative research opportunities with minimal barriers and maximal flexibility,
while ensuring accountability and transparency in scientific and budgetary decisions. The
Administrative Core fosters in-depth communication among all SPORE components to enhance
research integration, provide critical scientific feedback, evaluate scientific progress, plan for
future opportunities, and assert translational focus.
项目摘要-总结(行政核心)
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
THEODORE S LAWRENCE其他文献
THEODORE S LAWRENCE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('THEODORE S LAWRENCE', 18)}}的其他基金
Molecularly Targeted Radiosensitization of Locally Advanced Cancers
局部晚期癌症的分子靶向放射增敏
- 批准号:
10554470 - 财政年份:2023
- 资助金额:
$ 19.24万 - 项目类别:
Targeting Stromal Influences on BCKA Addiction in PDAC Tumors
靶向基质对 PDAC 肿瘤 BCKA 成瘾的影响
- 批准号:
10453984 - 财政年份:2022
- 资助金额:
$ 19.24万 - 项目类别:
Targeting Stromal Influences on BCKA Addiction in PDAC Tumors
靶向基质对 PDAC 肿瘤 BCKA 成瘾的影响
- 批准号:
10581670 - 财政年份:2022
- 资助金额:
$ 19.24万 - 项目类别:
Development of a first-in-class mEGFR dimerization inhibitor
开发一流的 mEGFR 二聚化抑制剂
- 批准号:
10591476 - 财政年份:2020
- 资助金额:
$ 19.24万 - 项目类别:
Development of a first-in-class mEGFR dimerization inhibitor
开发一流的 mEGFR 二聚化抑制剂
- 批准号:
10435117 - 财政年份:2020
- 资助金额:
$ 19.24万 - 项目类别:
Development of a first-in-class mEGFR dimerization inhibitor
开发一流的 mEGFR 二聚化抑制剂
- 批准号:
10369006 - 财政年份:2020
- 资助金额:
$ 19.24万 - 项目类别:
Development of a first-in-class mEGFR dimerization inhibitor
开发一流的 mEGFR 二聚化抑制剂
- 批准号:
10778673 - 财政年份:2020
- 资助金额:
$ 19.24万 - 项目类别:
Sensitization to Chemoradiation by Therapeutic Targeting of the DNA Damage Response
通过 DNA 损伤反应的治疗靶向来提高放化疗敏感性
- 批准号:
9901492 - 财政年份:2017
- 资助金额:
$ 19.24万 - 项目类别:
Mechanism-Based Use of Chk1 Inhibitors in Pancreas Cancer
基于机制的 Chk1 抑制剂在胰腺癌中的应用
- 批准号:
7891047 - 财政年份:2010
- 资助金额:
$ 19.24万 - 项目类别:
P3 - Mechanism-Based Use of Chk1 Inhibitors in Pancreas Cancer
P3 - Chk1 抑制剂在胰腺癌中基于机制的使用
- 批准号:
7893334 - 财政年份:2010
- 资助金额:
$ 19.24万 - 项目类别:
相似海外基金
Collaborative Research: OPUS: Permutational Biometry: Synthesizing the Analytics of Data Analysis in Ecology and Evolution
合作研究:OPUS:排列生物测定:综合生态学和进化中的数据分析
- 批准号:
2146220 - 财政年份:2022
- 资助金额:
$ 19.24万 - 项目类别:
Standard Grant
Collaborative research: OPUS: Permutational Biometry: Synthesizing the Analytics of Data Analysis in Ecology and Evolution
合作研究:OPUS:排列生物测定:综合生态学和进化中的数据分析
- 批准号:
2140720 - 财政年份:2022
- 资助金额:
$ 19.24万 - 项目类别:
Standard Grant
An optical biometry approach for vision screening in preschool children
用于学龄前儿童视力筛查的光学生物测量方法
- 批准号:
17K13249 - 财政年份:2017
- 资助金额:
$ 19.24万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
High-resolution biometry and morphometric characterization of calcareous nannofossils during the Oceanic Anoxic Events 1a and 1d in a global context
全球背景下海洋缺氧事件 1a 和 1d 期间钙质超微化石的高分辨率生物测量和形态特征
- 批准号:
241525448 - 财政年份:2013
- 资助金额:
$ 19.24万 - 项目类别:
Infrastructure Priority Programmes














{{item.name}}会员




